Raises More Than $1M In Financing And Enters Into Strategic Pacific Rim Partnership – The Street

//Raises More Than $1M In Financing And Enters Into Strategic Pacific Rim Partnership – The Street

Raises More Than $1M In Financing And Enters Into Strategic Pacific Rim Partnership – The Street

MacuCLEAR, Inc., a specialty clinical stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, today announced it has secured more than $1M in funds from current investors.  The funds will be used to complete a pivotal, Phase 3a human efficacy trial for its lead product, MC-1101.  Concurrently, MacuCLEAR has also entered into a strategic partnership with a Pacific Rim pharmaceutical partner and investor to finance clinical costs, bridging studies and regulatory development for MC-1101 in the territory.

Read the Full Article
2017-05-23T18:33:43+00:00 January 3, 2012|Categories: In the News|0 Comments